Dr. Hönle AG (HNL) — Capital Reinvestment Ratio

Latest as of September 2025: 0.16x

Dr. Hönle AG (HNL) has a Capital Reinvestment Ratio of 0.16x as of September 2025, meaning it reinvests 0% of its operating cash flow (€2.96 Million) in capital expenditures (€469.00K). See net asset quality index of Dr. Hönle AG to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.16x
Capex / Operating Cash Flow

Operating Cash Flow

€2.96 Million
EUR

Capital Expenditures

€469.00K
EUR

Data as of

Sep 2025
Most recent filing

Dr. Hönle AG Capital Reinvestment Ratio (2014–2025)

This chart tracks Dr. Hönle AG's Capital Reinvestment Ratio across 11 annual periods. Check HNL cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Dr. Hönle AG (2014–2025)

Year-by-year Capital Reinvestment Ratio for Dr. Hönle AG from 2014 to 2025. For live market cap and broader valuation context, see Dr. Hönle AG (HNL) total market value.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.38x €4.99 Million €1.90 Million ▲ +0.5%
2024 0.38x €5.53 Million €2.09 Million ▼ -59.4%
2023 0.93x €3.14 Million €2.93 Million ▼ -93.8%
2021 15.12x €1.13 Million €17.09 Million ▲ +262.3%
2020 4.17x €7.23 Million €30.20 Million ▲ +266.5%
2019 1.14x €16.92 Million €19.28 Million ▲ +160.8%
2018 0.44x €24.22 Million €10.58 Million ▼ -46.4%
2017 0.81x €6.58 Million €5.36 Million ▲ +41.3%
2016 0.58x €8.63 Million €4.98 Million ▲ +147.3%
2015 0.23x €9.16 Million €2.14 Million ▼ -43.4%
2014 0.41x €7.49 Million €3.08 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow